Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Anti-tumor activity against multiple myeloma by combination of KW-2478, an Hsp90 inhibitor, with bortezomib.

Ishii T, Seike T, Nakashima T, Juliger S, Maharaj L, Soga S, Akinaga S, Cavenagh J, Joel S, Shiotsu Y.

Blood Cancer J. 2012 Apr;2(4):e68. doi: 10.1038/bcj.2012.13. Epub 2012 Apr 27.

2.

Methylseleninic acid antagonizes the cytotoxic effect of bortezomib in mantle cell lymphoma cell lines through modulation of Bcl-2 family proteins.

Kassam S, Juliger S, Jia L, Joel SP.

Br J Haematol. 2012 Jan;156(2):286-9. doi: 10.1111/j.1365-2141.2011.08861.x. Epub 2011 Sep 13. No abstract available.

PMID:
21910718
3.

Methylseleninic acid inhibits HDAC activity in diffuse large B-cell lymphoma cell lines.

Kassam S, Goenaga-Infante H, Maharaj L, Hiley CT, Juliger S, Joel SP.

Cancer Chemother Pharmacol. 2011 Sep;68(3):815-21. doi: 10.1007/s00280-011-1649-1. Epub 2011 Apr 26.

PMID:
21519842
4.
5.

The proteasome inhibitor bortezomib acts independently of p53 and induces cell death via apoptosis and mitotic catastrophe in B-cell lymphoma cell lines.

Strauss SJ, Higginbottom K, Jüliger S, Maharaj L, Allen P, Schenkein D, Lister TA, Joel SP.

Cancer Res. 2007 Mar 15;67(6):2783-90.

6.

AGRO100 inhibits activation of nuclear factor-kappaB (NF-kappaB) by forming a complex with NF-kappaB essential modulator (NEMO) and nucleolin.

Girvan AC, Teng Y, Casson LK, Thomas SD, Jüliger S, Ball MW, Klein JB, Pierce WM Jr, Barve SS, Bates PJ.

Mol Cancer Ther. 2006 Jul;5(7):1790-9.

7.

Analysis of polymorphic sites in the promoter of the nitric oxide synthase 2 gene.

Coia V, Jüliger S, Mordmüller B, Kreidenweis A, Stroh AL, Ortega C, Vindigni A, Dengjel J, Lukyanov DV, Destro-Bisol G, Fedorov A, Podgornaya OI, Kun JF.

Biochem Biophys Res Commun. 2005 Oct 7;335(4):1123-31.

PMID:
16105645
8.

Genetic variants of the mannan-binding lectin are associated with immune reactivity to mannans in Crohn's disease.

Seibold F, Konrad A, Flogerzi B, Seibold-Schmid B, Arni S, Jüliger S, Kun JF.

Gastroenterology. 2004 Oct;127(4):1076-84.

PMID:
15480986
9.

Functional analysis of a promoter variant of the gene encoding the interferon-gamma receptor chain I.

Jüliger S, Bongartz M, Luty AJ, Kremsner PG, Kun JF.

Immunogenetics. 2003 Jan;54(10):675-80. Epub 2002 Dec 14. Erratum in: Immunogenetics. 2003 Mar;54(12):911.

PMID:
12557053
10.

Mannose-binding lectin gene polymorphisms and hepatitis B virus infection in Vietnamese patients.

Song le H, Binh VQ, Duy DN, Jüliger S, Bock TC, Luty AJ, Kremsner PG, Kun JF.

Mutat Res. 2003 Jan 28;522(1-2):119-25.

PMID:
12517417
11.

Restricted polymorphisms of the mannose-binding lectin gene in a population of Papua New Guinea.

Jüliger S, Kremsner PG, Alpers MP, Reeder JC, Kun JF.

Mutat Res. 2002 Aug 29;505(1-2):87-91.

PMID:
12175909
12.

Promoter variants of the human mannose-binding lectin gene show different binding.

Jüliger S, Luckner D, Mordmüller B, May J, Weierich A, Lell B, Luty A, Kremsner PG, Kun JF.

Biochem Biophys Res Commun. 2000 Aug 28;275(2):617-22.

PMID:
10964713

Supplemental Content

Loading ...
Support Center